Eisai Publishes Potential Economic Value of Investigational Lecanemab in Peer-Reviewed Neurology and Therapy Journal
Second Publication on the Potential Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation ModelingTOKYO, June 22, 2022 - (JCN Newswire) - Eisai Co., Ltd. today announced publication
Source: finanznachrichten.de